PUBLIC COMPANY
save$APLMApollomics Inc.
$APLMFoster City, CA, USupdated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1APL-102 Capsule in Patients With Advanced Solid Tumors
- phase3Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML
- phase1Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients
- phase2APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Insider activity
source: SEC Form 4routine RSU / option mechanics (1)
- Mar 31, 26tax coverLIN PETER KUAN-HOW · Chief Financial Officer3,582 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 32m ago
Found something off?
comments(0)
5-min edit window · permanent after that